Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

13.5%

6.4¢ percheron therapeutics limited

Chart, page-5531

First 5531 Last

Share
Profile

Follow
RYNZN

2,903 Posts.

436

06/08/22

14:08

Post #: 62962384
Share

Originally posted by mac9: ↑

Hi Itsa,
if the trial in DMD goes well, it will be commercialised.
If there are 26000 boys in the EU and being conservative we look at 50% being nonambulant, and then we were to get 50% of those boys being treated with ATL-1102 there would be 6500x$100,000 which equals $650m
If we took $150m expenses to earn $650 it would leave about $500m profit.
With a conservative PE of only x10 that would have the share price at approx $5.00

This is all back-of-napkin conversation, and all erring on the very conservative side and doesn't include the US or other non-EU regions.
It doesn't include any other indications or ailments, just non-ambulent DMD EU boys.
It also doesn't focus on ramp up or also down, it's a generic median.

Loose discussion but indicative.

Expand

Could easily be x $250k per boy (lot cheaper than 1m sarepta) x 20 pe due to future applications, $25

Last edited by RYNZN: 06/08/22

ANP Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 375 more messages in this thread...

First 5531 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 6.4¢		Change -0.010(13.5%)		Mkt cap ! $57.69M

Open	High	Low	Value	Volume
7.4¢	7.6¢	5.9¢	$516.4K	8.992M

Buyers (Bids)

No.	Vol.	Price($)
2	339429	6.4¢

Sellers (Offers)

Price($)	Vol.	No.
6.9¢	13	1

View Market Depth

No.	Vol.	Price($)
2	339429	0.064
1	8350	0.061
2	41666	0.060
2	106000	0.056
2	180000	0.055

Price($)	Vol.	No.
0.076	143169	1
0.078	50000	1
0.079	20000	1
0.080	120000	1
0.082	20000	1

Last trade - 16.10pm 24/04/2024 (20 minute delay)


Last 5.9¢			Change -0.010 ( 21.3 %)
Open	High		Low	Volume
7.6¢	7.6¢		5.9¢	132018
Last updated 15.49pm 24/04/2024 ?

PER (ASX) Chart